WellTheory, founded in 2021, is pioneering a transformative approach to address the swiftly rising prevalence of autoimmune conditions, which currently affect over 50 million Americans. Their mission, encapsulated by their slogan, "On a mission to reverse the autoimmune epidemic," highlights a deep commitment to reshaping how these conditions are understood and managed.
The company's innovative model integrates personalized care, scientific research, and artificial intelligence to provide effective symptom relief and enhance quality of life for patients. By doing so, WellTheory also aims to help employers and payors reduce healthcare costs.
The company's progress is supported by a significant $7.20M Seed Round investment secured on 09 November 2022, involving renowned investors such as Susa Ventures, BoxGroup, Lux Capital, Scribble Ventures, Coalition Operators, Karman Ventures, Rock Health Capital, OVO, and Steph Korey Goodwin. Operating in the Health Care and Health and Wellness industries, WellTheory represents a compelling opportunity for further investment in transformative health solutions.
